{'url': 'https://www.cancer.gov/news-events/cancer-currents-blog/2018/kidney-cancer-fda-nivolumab-ipilimumab-first-line', 'method': 'GET', 'status': 200, 'response_url': 'https://www.cancer.gov/news-events/cancer-currents-blog/2018/kidney-cancer-fda-nivolumab-ipilimumab-first-line', 'timestamp': 1711315310.5146255}